| abstract |
(57) [Summary]nThe present invention relates to the treatment of erectile dysfunction using a combination of (1) a compound selected from α-adrenergic receptor antagonists and (2) a compound selected from agents that increase cGMP levels. Sildenafil or a pharmaceutically acceptable salt thereof is suitable as a cGMP PDE elevating agent. The invention also includes compositions and kits containing such impotence treatment compounds. |